Summary
Alcon: Some Premium Coming Out Of This Quality Play
Alcon Inc. remains a global leader in eye care, benefiting from aging demographics and technological innovation, but faces valuation and growth headwinds. Recent M&A activity, including the pending STAAR Surgical deal, pressures near-term earnings and adds uncertainty, despite strategic fit. ALC shares have declined from highs, now trading at a more reasonable 25 times earnings, but growth is slowing, and valuation remains somewhat elevated.
ALC's Q3 Earnings Beat, Revenues Miss, Stock Rises in After-Market Hours
Alcon posts mixed Q3 results as earnings top estimates but revenues miss; new product launches fuel optimism.
Alcon (ALC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Alcon (ALC) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Alcon Inc. (ALC) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
What is the earnings per share?
When is the next earnings date?
Has Alcon Inc. ever had a stock split?
Alcon Inc. Profile
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | David J. Endicott CEO | NYSE Exchange | H01301128 CUSIP |
| CH Country | 25,599 Employees | 14 May 2025 Last Dividend | - Last Split | - IPO Date |
Overview
Alcon Inc. is a global leader in eye care, specializing in the research, development, manufacturing, distribution, and sales of a wide range of eye care products. Catering to both eye care professionals and patients, Alcon's mission is to enhance vision and improve people's lives through innovative products and solutions. The company's portfolio spans across surgical procedures and vision care, addressing a broad spectrum of eye health needs. Originally founded in 1945 as Alcon Universal S.A., the company underwent a name change to Alcon Inc. in December 2001 and has since established its headquarters in Geneva, Switzerland, marking its presence as a key player in the eye care industry on a global scale.
Products and Services
Alcon Inc.'s offerings are divided into two main segments: Surgical and Vision Care, each catering to distinct aspects of eye health and surgery.
- Surgical Segment:
- Vision Care Segment:
Within the surgical field, Alcon provides a comprehensive array of products including equipment, instrumentation, diagnostics, intraocular lenses (IOLs), and other implantables, along with various consumables. These specialized products support a wide range of procedures from cataract surgery to vitreoretinal operations. Notable products within this segment include the Centurion Vision System, LenSx Laser System for cataract treatment, Constellation Vision Systems for vitreoretinal surgeries, and the WaveLight Lasers for LASIK treatments. Additionally, Alcon offers innovative solutions like the NGENUITY 3D Visualization System and the ORA system for enhanced surgical precision and outcomes. Custom surgical packs and a variety of manual surgical instruments further complement Alcon’s surgical offerings.
Alcon’s Vision Care segment focuses on enhancing daily eye health and visual comfort through a wide range of products. This includes daily disposable, reusable, and color-enhancing contact lenses designed to meet diverse needs and preferences. Beyond corrective lenses, Alcon provides solutions for common eye concerns such as dry eye, ocular allergies, and glaucoma, as well as products for contact lens care. The segment is also home to ocular vitamins and redness relievers, aimed at maintaining overall eye health and comfort.
Contact Information
